Chlamydia Screening (CHL)
According to the Minnesota Department of Health (MDH), chlamydia is the most commonly reported sexually transmitted infection (STI) in the nation, as well as in Minnesota. The number of chlamydia cases has doubled over the last 10 years and affects all regions of Minnesota. In order to reduce complications and associated high medical costs, routine screening of adolescents and young adults for chlamydia is necessary, as many cases are asymptomatic.
Who was measured?
Women ages 16 – 24 as of December 31 of the measurement year who were continuously enrolled in Families and Children or MinnesotaCare with no more than one 45-day gap within the Healthcare Effectiveness Data and Information Set (HEDIS®)1 measurement year and who were identified as being sexually active were measured.
Our results are shown in the graph below. Also shown are the state average national average for measurement year 2024.
F&C = Families and Children, MNCARE = MinnesotaCare
What can providers do?
PrimeWest Health urges providers to screen all young adults for chlamydia. Remember, a simple urine sample can be used for screening.
1HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA)
PW_2011_171
Updated_08/25/2026
